top of page
  • Writer's pictureLaurent DECORY

Right-sizing, not downsizing, for post-covid

Covid-19 pandemic has created roller-coaster situations for Pharma and MedTech companies.

For post-covid commercial restart, life science companies need to prepare for right sizing, not downsizing.

It could mean different setup, new capabilities, or move to omni-channel.

BlueJet Consulting can help !

Continue reading


bottom of page